zintick

Corcept Therapeutics CORT

Corcept Therapeutics Inc · Nasdaq · Pharmaceutical Preparations

$86.28-1.50%close on Oct. 28, 2026 · volume 1.0M · Yahoo Finance

Price, last 47 sessions

$90.00$100.00$110.00$120.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $123.57 · low $85.86 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 15, 2026James N. Wilson
director · indirect
Sold
10b5-1 plan
10,000$114.81
$114.48-$116.30
$1.15 million
Oct. 2, 2026Roberto Wandenkolk Vieira
President, Oncology
Sold
10b5-1 plan
8,333$116.10
$114.52-$116.59
$967,448
Oct. 2, 2026Joseph Douglas Lyon
See Remarks
Sold
10b5-1 plan
9,190$116.13
$115.70-$116.54
$1.07 million
Oct. 2, 2026Sean Maduck
See Remarks
Sold
10b5-1 plan
24,587$116.28
$116.12-$116.55
$2.86 million
Oct. 1, 2026Joseph Douglas Lyon
See Remarks
Sold
10b5-1 plan
810$115.40$93,473
Oct. 1, 2026Sean Maduck
See Remarks
Sold
10b5-1 plan
413$115.54$47,717
Sept. 16, 2026Roberto Wandenkolk Vieira
President, Oncology
Sold
10b5-1 plan
296$100.82$29,843
Sept. 15, 2026James N. Wilson
director · indirect
Sold
10b5-1 plan
10,000$110.69
$110.27-$111.70
$1.11 million
Sept. 14, 2026Joseph Douglas Lyon
See Remarks
Sold
10b5-1 plan
10,000$113.49
$113.32-$114.12
$1.13 million
Sept. 2, 2026Roberto Wandenkolk Vieira
President, Oncology
Sold
10b5-1 plan
58,333$110.76
$109.35-$115.44
$6.46 million
Sept. 1, 2026Sean Maduck
See Remarks
Sold
10b5-1 plan
25,000$114.43
$113.94-$115.61
$2.86 million
Aug. 26, 2026Kimberly Park
director
Sold26,685$122.55$3.27 million

Latest 12 of 23. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 34 →